CLINICAL_TRIALS
trial_result
· 2017-10-19
Clinical Trial Update: Rituximab in Auto-Immune Hemolytic Anemia [Phase 3]
Summary
A Phase 3 trial evaluating Rituximab for warm autoimmune hemolytic anemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Warm Autoimmune Hemolytic Anemia | Phase 3 | Status: COMPLETED